(Q28248331)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Wang J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Zeevi A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Webber SA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Girnita DM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Selby R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Fu J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Shah T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Pravica V

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hutchinson IV

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Burckart GJ

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

12 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

711-717

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17851563%20AND%20SRC:MED&resulttype=core&format=json

A mutational analysis of the active site of human type II inosine 5'-monophosphate dehydrogenase

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

Mycophenolate mofetil and its mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Mycophenolate Mofetil for Myasthenia Gravis A Double‐Blind, Placebo‐Controlled Pilot Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Regulation of inosine-5'-monophosphate dehydrogenase type II gene expression in human T cells. Role for a novel 5' palindromic octamer sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Review: metabolism of immunosuppressant drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Progress in the clinical application of immunosuppressive drugs in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Race/ethnicity, poverty status, and renal transplant outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Rabbit antithymocyte globulin versus basiliximab in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The effect of Daclizumab in a high-risk renal transplant population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Pharmacogenomics and lung transplantation: clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100347

7 January 2021